CDK4 and breast carcinoma: CCDN1 amplification, encoding CyclinD1, results in chromosomal instability via CDT1,34 consistent with our gene expression findings, suggesting that CDK4/6 inhibitors may also have a role for the treatment of this subgroup of breast cancer.